Drug
Vemircopan clinical trials
Also written ALXN2050 and ACH-0145228.
- studies test it
- 17
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Development codes
- ALXN2050
- 15
Studies by the year they started
17 studies that test it; most in 2022 (5)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 14
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 17 · Other 0
Often tested with
Tested in the same studies.
Fluconazole (1) · Rifampin (1) · Rosuvastatin (1) · Metformin (1) · Levonorgestrel (1) · Ethinyl Estradiol (1) · Carbamazepine (1) · Cyclosporine (1)
Studies
Open first, then newest update. How each study uses vemircopan is read from its arms, and is right about nine times in ten.
Testing it · 17
- Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult ParticipantsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT04933682Written as ALXN2050
- Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)TerminatedPhase 2Alexion Pharmaceuticals, Inc.NCT05097989Written as ALXN2050
- Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and CarbamazepineCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT06071442Written as Vemircopan
- Study of ALXN2050 in Participants With Hepatic ImpairmentTerminatedPhase 1Alexion Pharmaceuticals, Inc.NCT05259085Written as ALXN2050
- Bioequivalence Between 180 mg and 60 mg ALXN2050 Tablets and Food Effect on ALXN2050 PharmacokineticsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT05578846Written as Treatment A
- Study of ALXN2050 in Adult Participants With Generalized Myasthenia GravisTerminatedPhase 2Alexion Pharmaceuticals, Inc.NCT05218096Written as ALXN2050
- Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as MonotherapyTerminatedPhase 2Alexion Pharmaceuticals, Inc.NCT04170023Written as ALXN2050
- A Study to Investigate the Pharmacokinetic Profile of ALXN2050 Modified Release Prototype Formulations and Immediate Release Reference Tablet in Healthy Adult ParticipantsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT05780645Written as ALXN2050 MR Prototype Tablet
- Study of ALXN2050 in Participants With Renal ImpairmentCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT04623710Written as ALXN2050
- Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult ParticipantsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT05202145Written as ALXN2050
- Study of Radiolabeled ALXN2050 in Healthy Adult MalesCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT04609670Written as [14C]-ALXN2050
- Study of ALXN2050 in Healthy Adult Participants of Japanese DescentCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT04952545Written as ALXN2050
- A Study of the Cardiac Effects of ALXN2050 in Healthy AdultsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT04660890Written as ALXN2050
- A Study to Assess ACH-0145228 When Administered as Immediate Release Tablet Versus Powder-In-Capsule in Healthy Adult ParticipantsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT04551586Written as ACH-0145228: Powder-in-capsule
- A Study of Single-dose ALXN2050 in Healthy AdultsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT05047458Written as ALXN2050
- A Study of Multiple Doses of ALXN2050 in Healthy AdultsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT05047484Written as ALXN2050
- A Drug Interaction Study of ACH-0145228CompletedPhase 1Alexion Pharmaceuticals, Inc.NCT04709081Written as ACH-0145228
Codes
What other systems call vemircopan · ClinicalTrials.gg INT016788
- UNII (FDA) HN6I4K50QBVEMIRCOPANOne source FDA
- NCI Thesaurus C174393VemircopanOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | HN6I4K50QB | VEMIRCOPAN | One source FDA |
| NCI Thesaurus | C174393 | Vemircopan | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.